Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

Details

Original languageEnglish
Pages (from-to)e39-e42
JournalHaematologica
Volume102
Issue number2
Publication statusPublished - Feb 2017
Peer-reviewedYes

External IDs

Scopus 85011601383
PubMed 27856510
PubMedCentral PMC5286951
ORCID /0000-0002-2524-1199/work/142251486

Keywords

Keywords

  • Adolescent, Antineoplastic Agents/therapeutic use, Child, Child, Preschool, Drug Administration Schedule, Female, Fusion Proteins, bcr-abl/antagonists & inhibitors, Gene Expression, Germany, Humans, Imatinib Mesylate/therapeutic use, Infant, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy, Male, Protein Kinase Inhibitors/therapeutic use, RNA, Messenger/antagonists & inhibitors, Treatment Outcome